F protein-subunit based vaccines ... Novavax is testing a postfusion F protein vaccine formulated with alum in both older adults and pregnant women. GlaxoSmithKline is evaluating a prefusion ...

mRNA vaccines and protein subunit vaccines. All COVID-19 vaccines provide protection from the virus that causes COVID-19. None of these vaccines can give a person COVID-19. FDA approved and authorized ...

A subunit vaccine makes use of just a small portion of a pathogen. For a virus, the vaccine can contain just a piece of the protein coat that surrounds the virus's DNA (or RNA). Even small portion ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

VLPs are made entirely of proteins and thus would make non-infectious and safe vaccine candidates. Here we presented short protein sequences on the surface of Orbivirus core-like particles (CLPs ...

NHPs that had been vaccinated with an adenovirus SARS-CoV-2 vaccine were administered a recombinant protein subunit vaccine (CiVax) approximately 7.5 months later. The post-booster antibody ...

This investigational multivalent protein subunit vaccine targets the outer surface protein A (OspA) of the bacterium Borrelia that causes the disease, an established mechanism of action for a Lyme ...

Learn about our Editorial Policies. Holz and her colleagues were inspired by the success of mRNA vaccines during the COVID-19 pandemic. “By using an mRNA-based vaccine, you can encode an entire ...

Detectable levels of the S1 subunit of the spike protein were seen in plasma up ... post-vaccination syndrome after receiving a COVID vaccine (11 females and 11 males) from the LISTEN study.